10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.84%
EBIT growth below 50% of CGAU's 586.65%. Michael Burry would suspect deeper competitive or cost structure issues.
31.84%
Operating income growth under 50% of CGAU's 586.65%. Michael Burry would be concerned about deeper cost or sales issues.
32.55%
Net income growth under 50% of CGAU's 591.82%. Michael Burry would suspect the firm is falling well behind a key competitor.
32.46%
EPS growth under 50% of CGAU's 566.67%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
32.46%
Diluted EPS growth under 50% of CGAU's 555.56%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
71.10%
OCF growth under 50% of CGAU's 197.38%. Michael Burry might suspect questionable revenue recognition or rising costs.
71.40%
FCF growth under 50% of CGAU's 279.90%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-81.60%
Negative 10Y OCF/share CAGR while CGAU stands at 3506.12%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-81.60%
Negative 5Y OCF/share CAGR while CGAU is at 3506.12%. Joel Greenblatt would question the firm’s operational model or cost structure.
-81.60%
Negative 3Y OCF/share CAGR while CGAU stands at 1306.72%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
75.43%
Below 50% of CGAU's 1926.10%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
75.43%
Below 50% of CGAU's 1926.10%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
75.43%
Below 50% of CGAU's 6786.12%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-78.19%
Negative equity/share CAGR over 10 years while CGAU stands at 36.21%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-78.19%
Negative 5Y equity/share growth while CGAU is at 36.21%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-78.19%
Negative 3Y equity/share growth while CGAU is at 24.28%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-61.71%
Firm’s AR is declining while CGAU shows 86.05%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Inventory is declining while CGAU stands at 7.94%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.10%
Negative asset growth while CGAU invests at 20.40%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-8.83%
We have a declining book value while CGAU shows 17.29%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-32.93%
We cut SG&A while CGAU invests at 43.60%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.